Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
80.3 USD | +0.34% | +2.74% | +40.61% |
May. 08 | Lemaitre Vascular Insider Sold Shares Worth $9,314,501, According to a Recent SEC Filing | MT |
May. 08 | Lemaitre Vascular Insider Sold Shares Worth $379,991, According to a Recent SEC Filing | MT |
Financials (USD)
Sales 2024 * | 215M | Sales 2025 * | 231M | Capitalization | 1.8B |
---|---|---|---|---|---|
Net income 2024 * | 40M | Net income 2025 * | 44M | EV / Sales 2024 * | 8.35 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 7.78 x |
P/E ratio 2024 * |
45.1
x | P/E ratio 2025 * |
41.2
x | Employees | 622 |
Yield 2024 * |
0.8% | Yield 2025 * |
0.85% | Free-Float | 84.65% |
Latest transcript on LeMaitre Vascular, Inc.
1 day | +1.61% | ||
1 week | +2.50% | ||
Current month | +23.49% | ||
1 month | +27.48% | ||
3 months | +31.87% | ||
6 months | +50.02% | ||
Current year | +40.98% |
Managers | Title | Age | Since |
---|---|---|---|
George LeMaitre
CEO | Chief Executive Officer | 59 | 92-05-31 |
David Roberts
PSD | President | 60 | 96-12-31 |
Director of Finance/CFO | 59 | 04-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
John Roush
BRD | Director/Board Member | 58 | 14-04-08 |
Director of Finance/CFO | 59 | 04-12-31 | |
John O'Connor
BRD | Director/Board Member | 76 | 08-09-16 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.96% | 11 M€ | -6.03% | - | |
0.45% | 28 M€ | -1.09% | ||
0.26% | 25 M€ | -2.18% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-23 | 79.81 | -0.26% | 13 127 |
24-05-22 | 80.02 | +1.61% | 89,918 |
24-05-21 | 78.75 | -0.81% | 47,262 |
24-05-20 | 79.39 | +1.20% | 89,777 |
24-05-17 | 78.45 | +0.99% | 77,077 |
Delayed Quote Nasdaq, May 22, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+40.98% | 1.8B | |
+11.31% | 226B | |
+15.50% | 198B | |
+18.83% | 142B | |
+30.38% | 111B | |
+2.59% | 65.26B | |
+18.31% | 54.36B | |
+4.96% | 50.94B | |
+9.95% | 44.8B | |
+4.27% | 36.8B |
- Stock Market
- Equities
- LMAT Stock